
IndraLab
Statements
Fexofenadine inhibits KCNH2. 3 / 3
|
3
reach
"In this study, we demonstrated that 1) cav-1 participates in BBR induced hERG deficiency on cell surface; 2) residues Tyr652 and Phe656, essential components of hERG binding sites, mediate hERG surface expression inhibition by BBR incubation; and 3) fexofenadine and resveratrol can shorten APD of ventricular cardiomyocytes prolonged by BBR."
reach
"HERG channel blockers, such as E4031, fexofenadine and astemizole, facilitated maturation of hERG proteins by acting as chemical chaperones XREF_BIBR; however, these agents can not be used clinically for enhancing hERG channel currents, because they acutely block the rapidly activating delayed-rectifier K + channel current (I Kr)."